- 英文名称:
- stanozolol--dea schedule iii
- 英文别名:
- Stanozolol; 17-alpha-methyl-5-alpha-androstano(3,2-c)pyrazol-17-beta-ol; ndrostanazol; Winstrol l; 17beta-Hydroxy-17-methyl-5alpha-androstano[3,2-c]pyrazole; Stanazolol; 1,10a,12a-trimethyl-1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol; (1S,3aS,3bR,5aS,10aS,10bS,12aS)-1,10a,12a-trimethyl-1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol
- InChI:
- InChI=1/C21H32N2O/c1-19-11-13-12-22-23-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,24H,4-11H2,1-3H3,(H,22,23)/t14-,15+,16-,17-,19-,20-,21-/m0/s1
- 分子结构:
-

- 沸 点:
- 490.8°C at 760 mmHg
- 蒸汽压:
- 1.89E-10mmHg at 25°C
- 产品用途:
- 用于慢性消耗性疾病、重病及手术后体弱消瘦、年老体弱、骨质疏松症、小儿发育不良、再生障碍性贫血等
©2013
www.idochem.com 苏ICP备10098795号 最全面的在线
化工词典数据库